טוען...
Standardizing T-Cell Biomarkers in Type 1 Diabetes: Challenges and Recent Advances
Type 1 diabetes (T1D) results from the progressive destruction of pancreatic β-cells in a process mediated primarily by T lymphocytes. The T1D research community has made dramatic progress in understanding the genetic basis of the disease as well as in the development of standardized autoantibody as...
שמור ב:
| הוצא לאור ב: | Diabetes |
|---|---|
| Main Authors: | , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Diabetes Association
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6609980/ https://ncbi.nlm.nih.gov/pubmed/31221801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db19-0119 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|